"现场快报"标签列表

What is the impact of higher sensitivity assay on response-guided therapy in hepatitis C virus(1)2007-11-14

Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (4)2007-11-14

Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (2)2007-11-14

Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (3)2007-11-14

Effect of Infliximab on the Efficacy of Peginterferon alfa-2b(PEG-2b) Plus Ribavirin(RBV) (1)2007-11-14

Differentiation of early virologic response (EVR) into RVR, complete EVR (cEVR) and partial EVR (5)2007-11-14

Differentiation of early virologic response (EVR) into RVR, complete EVR (cEVR) and partial EVR (4)2007-11-14

Differentiation of early virologic response (EVR) into RVR, complete EVR (cEVR) and partial EVR (2)2007-11-14

Differentiation of early virologic response (EVR) into RVR, complete EVR (cEVR) and partial EVR (3)2007-11-14

Differentiation of early virologic response (EVR) into RVR, complete EVR (cEVR) and partial EVR (1)2007-11-14

Patients co-infected with HCV and HIV who achieve and RVR (HCV RNA<50LU/ML at week 12) (4)2007-11-14

Patients co-infected with HCV and HIV who achieve and RVR (HCV RNA<50LU/ML at week 12) (5)2007-11-14

Patients co-infected with HCV and HIV who achieve and RVR (HCV RNA<50LU/ML at week 12) (3)2007-11-14

Patients co-infected with HCV and HIV who achieve and RVR (HCV RNA<50LU/ML at week 12) (2)2007-11-14

Patients co-infected with HCV and HIV who achieve and RVR (HCV RNA<50LU/ML at week 12) (1)2007-11-14

Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(4)2007-11-13

Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(5)2007-11-13

Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(2)2007-11-13

Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(3)2007-11-13

Response-guided therapy in a prospective trial of peginterferon alfa-2a(40KD)/ribavirin(1)2007-11-13